Neratinib in HER2-Mutant, Metastatic Cervical Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Gynecologic Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Neratinib in Patients With HER2-Mutant, Metastatic Cervical Cancer: Findings From the Phase 2 SUMMIT Basket Trial
Gynecol. Oncol 2020 Jul 25;[EPub Ahead of Print], A Oaknin, CF Friedman, LD Roman, A D'Souza, I Brana, F Clement-Bidard, J Goldman, EA Alvarez, V Boni, AC ElNaggar, R Passalacqua, KTM Do, AD Santin, K Keyvanjah, F Xu, LD Eli, AS Lalani, RP Bryce, DM Hyman, F Meric-Bernstam, DB Solit, BJ MonkFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.